(Q44477974)

3 December 2017

title

Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents? (English)

1 reference

3 December 2017

1 reference

Martin L Freeman

1

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

124

1 reference

3 December 2017

issue

7

1 reference

3 December 2017

page(s)

1977-1980

1 reference

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Adverse outcomes of ERCP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Complications of endoscopic biliary sphincterotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Risk factors for post-ERCP pancreatitis: a prospective, multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Complications of diagnostic and therapeutic ERCP: a prospective multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Bedside scoring system to predict the risk of developing pancreatitis following ERCP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Pancreatic stents can induce ductal changes consistent with chronic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

Endoscopic sphincterotomy complications and their management: an attempt at consensus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900553-5

10.1016/S0016-5085(03)00553-5

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference